APA (7th ed.) Citation

B, E., L, A., EJM, K., CW, M. d. H. v. O., B, v. d. V., AWJM, G., . . . CP, S. (2026). Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer. Diagnostics (Basel, Switzerland), 16(8), . https://doi.org/10.3390/diagnostics16081197

Chicago Style (17th ed.) Citation

B, Eisses, et al. "Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer." Diagnostics (Basel, Switzerland) 16, no. 8 (2026). https://doi.org/10.3390/diagnostics16081197.

MLA (9th ed.) Citation

B, Eisses, et al. "Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer." Diagnostics (Basel, Switzerland), vol. 16, no. 8, 2026, https://doi.org/10.3390/diagnostics16081197.